Experimental and clinical research is an important focus of the Department of Medicine II. In particular, our scientific focus on liver immunology is integrated or associated with several working groups in national and international collaborative projects, such as
Transregio-SFBTRR179 (Determinants and dynamics of elimination versus persistence of hepatitis virus infections)
SFB 1160 (Immune-mediated pathology as a consequence of disturbed immune reactions (IMPATH))
IP-cure-B (Immune profiling to guide host-directed interventions to cure HBV infections)
COVIPA: SARS-CoV-2 vaccines: a balance between protection and immunopathology
OncoEscape - Collaborative Research Center (CRC) 1479 "Oncogene-driven immune escape"
DZIF - German Center for Infection Research
DKTK - German Consortium for Translational Cancer Research
NUM - Network University Medicine
COVIM - Determination and use of SARS-CoV-2 immunity
Our clinic also plays a leading role in various doctoral programs, graduate schools and clinician scientist programs, such as
MOTI-VATE doctoral program of the Faculty of Medicine Freiburg
http://www.med.uni-freiburg.de/de/verwaltung/akademische-angelegenheiten/promotionen-1/moti-vate
EXCEL (Excellent Clinician Scientists in Freiburg - Education for Leadership: Immunological Causes and Therapies of Cancer)
https://www.uniklinik-freiburg.de/medizin2/aus-und-weiterbildung/excel.html
IMM-PACT Targeting common principles of immune mediated disease: from basic science to novel therapies
https://www.med.uni-freiburg.de/de/forschung/karrierewege/imm-pact
IMMediate Advanced Clinician Scientist Program
https://www.med.uni-freiburg.de/de/forschung/karrierewege/imm-pact